SCHEMBL13504459

SCHEMBL13504459

CC(C)(C)OC(=O)N1CCCC(Nc2cccc3nc(Nc4ccc(C#N)cc4)nn23)C1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 5/20 0.51
▸ JAK3 P52333 4/20 0.51
▸ PTK2 Q05397 3/20 0.48
▸ BTK Q06187 2/20 0.44
▸ USP30 Q70CQ3 2/20 0.43
▸ PARP1 P09874 1/20 0.42
▸ TRPV1 Q8NER1 1/20 0.41
▸ PIM1 P11309 2/20 0.40
▸ PIM2 Q9P1W9 2/20 0.40
▸ EGLN2 Q96KS0 2/20 0.40
▸ GPR119 Q8TDV5 3/20 0.40
▸ JAK1 P23458 1/20 0.39
▸ KDM1A O60341 1/20 0.39
▸ IGF1R P08069 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13504460 1.00 JAK2 (0.51) JAK2JAK3PTK2BTKUSP30
SCHEMBL3305295 0.89 JAK2 (0.46) JAK2JAK3PTK2BTKUSP30
SCHEMBL3305298 0.89 JAK2 (0.46) JAK2JAK3PTK2BTKUSP30
SCHEMBL3297909 0.88 EGLN2 (0.42) JAK2JAK3PTK2EGLN2JAK1
SCHEMBL3309857 0.87 JAK2 (0.46) JAK2JAK3PTK2BTKPARP1
SCHEMBL13504477 0.83 JAK2 (0.44) JAK2JAK3PTK2EGLN2JAK1
SCHEMBL13504479 0.83 JAK2 (0.44) JAK2JAK3PTK2EGLN2JAK1
SCHEMBL3304793 0.81 JAK2 (0.44) JAK2JAK3PTK2BTKUSP30
SCHEMBL3304788 0.81 JAK2 (0.44) JAK2JAK3PTK2BTKUSP30
SCHEMBL3302958 0.81 USP30 (0.50) JAK2JAK3BTKUSP30PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344494-B1 AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS SIGNAL PHARM LLC (US) 2016-04-20 — — EP disclosed
US-8299056-B2 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith SIGNAL PHARMACEUTICALS, LLC (US) 2012-10-30 — — US disclosed
Send feedback